Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Self-harm is a major public health concern and a risk factor for future suicide. It predominantly occurs in young people with around 65% of self-harm occurring before the age of 35. Self-harm causes distress to families and is associated with poorer educational outcomes as well as increased health and social care costs. Repetition is common with a quarter of individuals presenting to hospital with a further episode of self-harm within a year. We review the evidence from randomised controlled trials of treatments for self-harm, focusing on pharmacological and psychological approaches. We then contrast this with the current observational evidence and reflect on the challenges and limitations of randomised controlled trials for the treatment of self-harm.

Original publication

DOI

10.1136/eb-2016-102420

Type

Journal article

Journal

Evid Based Ment Health

Publication Date

08/2016

Volume

19

Pages

69 - 72

Keywords

Adolescent, Antidepressive Agents, Child, Cognitive Behavioral Therapy, Evidence-Based Medicine, Humans, Risk Factors, Self-Injurious Behavior, Suicide, Young Adult